Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario. Octava revisión. Colima 2019
Por:
Cárdenas-Sánchez J., Erazo Valle-SolÃs A.A., Arce-Salinas C., Bargalló-Rocha J.E., Bautista-Piña V., Cervantes-Sánchez G., Flores-Balcázar C.H., Lluch-Hernández A., Maffuz-Aziz A., Pérez-Sánchez V.M., Poitevin-Chacón A., Salas-González E., Torrecillas-Torres L., Valero-Castillo V.
Publicada:
1 ene 2019
Resumen:
Breast cancer is the most common neoplasm in women worldwide, as well as in our country. However, in Mexico there are differences that are important to identify and individualize in order to improve the outcomes of women suffering from this disease. Thus, the purpose of this 8th consensus review is to provide a national updated guideline, based on the best scientific evidence, and adjusted to the heterogeneity of our health system and to the existing needs and therapeutic coverage. Worldwide, breast cancer treatment is acknowledged as being multimodal, and therefore it requires a multidisciplinary group to help make the best therapeutic decisions. Hence, the conclusions of this consensus provide the best evidence to guide surgical, radiotherapy and systemic treatment, based on patient, tumor and the health system characteristics. Finally, in this edition, special emphasis is made on the need to establish an early and accurate diagnosis and to start the indicated therapy as soon as possible, since the delay in treatment implementation has been shown to negatively affect the survival rate. © 2018 Sociedad Mexicana de OncologÃa. Publicado por Permanyer México SA de CV.
Filiaciones:
Cárdenas-Sánchez J.:
Instituto Estatal de CancerologÃa, Colima, Col., Mexico
Erazo Valle-SolÃs A.A.:
Centro Médico Nacional 20 de Noviembre, ISSSTE, Ciudad de México, Mexico
Arce-Salinas C.:
Instituto Nacional de CancerologÃa, SS Ciudad de México, Mexico
Bargalló-Rocha J.E.:
Instituto Nacional de CancerologÃa, Ciudad de México, Mexico
Bautista-Piña V.:
Instituto de Enfermedades de la Mama, FUCAM, Ciudad de México, Mexico
Cervantes-Sánchez G.:
Centro Médico Nacional 20 de Noviembre, ISSSTE, Ciudad de México, Mexico
Flores-Balcázar C.H.:
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico
Lluch-Hernández A.:
Hospital ClÃnico Valencia, Spain
Maffuz-Aziz A.:
Centro Médico ABC, Ciudad de México, Mexico
Pérez-Sánchez V.M.:
Instituto Nacional de CancerologÃa, Ciudad de México, Mexico
Poitevin-Chacón A.:
Médica sur, Ciudad de México, Mexico
Salas-González E.:
Centro Médico de Occidente, IMSS Guadalajara, Jal., Mexico
Torrecillas-Torres L.:
Centro Médico Nacional 20 de Noviembre, ISSSTE, Ciudad de México, Mexico
Valero-Castillo V.:
Anderson Cancer Center, Houston, TX, United States
|